Obiettivo
Protein aggregation is a hallmark of many late onset neurodegenerative disorders including Parkinson’s Disease (PD), Alzheimer’s Disease (AD), amyotrophic lateral sclerosis (ALS), prion diseases as well as the group of polyglutamine diseases (polyQ). The aim of this proposal is to create a network of European partners bridging important basic mechanisms involved in proteinopathies, research of model diseases and treatment approaches. The “TreatPolyQ” network will focus on two main representatives of the polyQ diseases: Huntington’s disease as the most common polyQ disease as well as spinocerebellar ataxia type 3 (SCA3) as the most frequent autosomal-dominantly inherited ataxia. Patients suffer from a multitude of neurological symptoms including movement abnormalities with late onset and in a progressive manner. Up to now, no treatment or cure is available. The network will be consisting of a rare combination of experts from basic and translational research, including a Nobel prize laureate, four industrial partners (two medium, and two small companies, all incorporated as full participants) and academic leaders of the field. The network not only focuses on one special aspect of a disease but spans several important disease-associated mechanism as well as promising treatment strategies for HD and SCA3 (protein transport, protein folding, protein degradation via both the ubiquitin-proteasome system and autophagy), likely to be important across a range of neurodegenerative diseases. In order to implement these research projects, extensive collaborations and temporarily personnel secondments of the involved researchers will take place, enhancing interdisciplinary transfer of knowledge. Beyond the personalized local training plan for each employed researcher within the Network, there will be 4 structured courses covering aspects ranging from structural biology to protein degradation to model organisms and drug development, including soft skill training.
Campo scientifico
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsprotein folding
- medical and health sciencesbasic medicineneurologyparkinson
- medical and health sciencesbasic medicineneurologyamyotrophic lateral sclerosis
Invito a presentare proposte
FP7-PEOPLE-2010-ITN
Vedi altri progetti per questo bando
Meccanismo di finanziamento
MC-ITN - Networks for Initial Training (ITN)Coordinatore
72074 Tuebingen
Germania
Mostra sulla mappa
Partecipanti (15)
80539 Munchen
Mostra sulla mappa
75231 Paris
Mostra sulla mappa
Partecipazione conclusa
2100 COPENHAGEN
Mostra sulla mappa
17177 Stockholm
Mostra sulla mappa
75794 Paris
Mostra sulla mappa
32000 Haifa
Mostra sulla mappa
CB2 1TN Cambridge
Mostra sulla mappa
1015 Lausanne
Mostra sulla mappa
3004 517 Coimbra
Mostra sulla mappa
WC2R 2LS London
Mostra sulla mappa
53100 SIENA
Mostra sulla mappa
2500 Valby
Mostra sulla mappa
F-75205 / 13 Paris
Mostra sulla mappa
22100 LUND
Mostra sulla mappa
Partecipazione conclusa
2750 BALLERUP
Mostra sulla mappa